Moneycontrol
Get App
Last Updated : Feb 04, 2020 12:52 PM IST | Source: Moneycontrol.com

Sun Pharma share price slips 1% on weak Q3 show by US subsidiary

Operating income shed 26.3 percent at USD 58.19 million and operating margin was at 39.4 percent versus 44.7 percent, YoY.

Representative Image.
Representative Image.
 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

Sun Pharmaceutical Industries share price slipped over 1 percent intraday on February 4 after its US subsidiary, Taro Pharmaceuticals, reported weak numbers for the quarter ended December 2019.

Taro Pharma's Q3 net profit was down 27.6 percent at $67.68 million against $93.5 million in the year-ago period.

Revenue was down 16.3 percent at $147.7 million versus $176.4 million, YoY.

Close

Its forex income stood at $3.3 million, while tax expense was at $2.87 million.

Operating income shed 26.3 percent at $58.19 million and operating margin was at 39.4 percent versus 44.7 percent, YoY.

At 1234 hours, Sun Pharmaceutical Industries was quoting at Rs 422.85, up Rs 5.35, or 1.28 percent, on the BSE.

Exclusive offer: Use code "BUDGET2020" and get Moneycontrol Pro's Subscription for as little as Rs 333/- for the first year.

First Published on Feb 4, 2020 12:52 pm
Sections
Follow us on